{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:15:47Z","timestamp":1781075747002,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.arbres.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T17:55:09Z","timestamp":1591811709000},"page":"305-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagn\u00f3stico de la infecci\u00f3n tuberculosa en pacientes inmunodeprimidos y\/o candidatos a terapias biol\u00f3gicas mediante el uso combinado de dos pruebas IGRA: T-SPOT.TB\/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB\/QuantiFERON TB Gold Plus"],"prefix":"10.1016","volume":"58","author":[{"given":"Ana","family":"Fern\u00e1ndez-Bl\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Arg\u00fcelles Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sabater-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Asensi \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Palacios Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2020.04.011_bib0125","unstructured":"World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. 2015 Disponible en: http:\/\/www.who.int\/tb\/post2015_strategy\/en\/"},{"key":"10.1016\/j.arbres.2020.04.011_bib0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.arbres.2020.04.011_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.arbres.2020.04.011_bib0140","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2020.04.011_bib0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive Value of Interferon-\u03b3 release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest."},{"key":"10.1016\/j.arbres.2020.04.011_bib0150","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon- \u03b3 release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.arbres.2020.04.011_bib0155","doi-asserted-by":"crossref","first-page":"303e1","DOI":"10.1016\/j.eimc.2015.11.022","article-title":"Guidelines for the use of interferon- \u03b3 release assays in the diagnosis of tuberculosis infection","volume":"34","author":"Santin","year":"2016","journal-title":"Enf Infec Microbiol Clin."},{"key":"10.1016\/j.arbres.2020.04.011_bib0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arbres.2015.04.016","article-title":"Documento de consenso sobre la prevenci\u00f3n y el tratamiento de la tuberculosis en pacientes candidatos a tratamiento biol\u00f3gico","volume":"52","author":"Mir Viladrich","year":"2016","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2020.04.011_bib0165","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00629-18","article-title":"Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay","volume":"56","author":"Siegel","year":"2018","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.arbres.2020.04.011_bib0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-\u03b3 release assays: A systematic review and meta-analysis","volume":"64","author":"Pourakbari","year":"2019","journal-title":"Adv Med Sci."},{"key":"10.1016\/j.arbres.2020.04.011_bib0175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jiac.2017.10.009","article-title":"Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan","volume":"24","author":"Takasaki","year":"2018","journal-title":"J Infect Chemother."},{"key":"10.1016\/j.arbres.2020.04.011_bib0180","doi-asserted-by":"crossref","first-page":"30617","DOI":"10.1038\/srep30617","article-title":"Evaluation of QuantiFERON-TB Gold Plus for Detection of Mycobacterium tuberculosis infection in Japan","volume":"6","author":"Yi","year":"2016","journal-title":"Sci Rep."},{"key":"10.1016\/j.arbres.2020.04.011_bib0185","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.arbres.2020.04.011_bib0190","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tube.2017.11.014","article-title":"A multicentre verification study of the QuantiFERON\u00ae -TB Gold Plus assay","volume":"108","author":"Pieterman","year":"2018","journal-title":"Tuberculosis (Edinb)."},{"key":"10.1016\/j.arbres.2020.04.011_bib0195","doi-asserted-by":"crossref","first-page":"e00614","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers","volume":"56","author":"Theel","year":"2018","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.arbres.2020.04.011_bib0200","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.02498-16","article-title":"Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting","volume":"55","author":"Moon","year":"2017","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.arbres.2020.04.011_bib0205","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00438-18","article-title":"Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients","volume":"56","author":"Ryu","year":"2018","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.arbres.2020.04.011_bib0210","unstructured":"Gobierno del Principado de Asturias, Consejer\u00eda de Sanidad; Direcci\u00f3n General de Salud P\u00fablica. Actualizaci\u00f3n de los procedimientos para el diagn\u00f3stico de la infecci\u00f3n tuberculosa latente (ITL) y la adquisici\u00f3n de tuberculina PPD en Asturias. 2015 Disponible en: https:\/\/www.astursalud.es\/documents\/31867\/36150\/Circular+DGSP+04_2015+Actualizacion+diagnostico+ITL.pdf\/0f1cd1b6-57fa-54e7-cf63-2f7bdbb13092"},{"key":"10.1016\/j.arbres.2020.04.011_bib0215","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201203-0430OC","article-title":"Test Variability of the QuantiFERON-TB Gold In-Tube Assay in Clinical Practice","volume":"187","author":"Metcalfe","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2020.04.011_bib0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jiac.2017.09.012","article-title":"Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-SPOT.TB for latent tuberculosis infection in rheumatoid arthritis","volume":"24","author":"Igari","year":"2018","journal-title":"J Infect Chemother."},{"key":"10.1016\/j.arbres.2020.04.011_bib0225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jiac.2017.04.002","article-title":"Comparison of interferon-\u03b3 release assays QuantiFERON TB-GIT and T-SPOT.TB, in renal transplantation","volume":"23","author":"Ishikawa","year":"2017","journal-title":"J Infect Chemother."},{"key":"10.1016\/j.arbres.2020.04.011_bib0230","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","article-title":"IFN-\u03b3 Release Assays in the Diagnosis of Latent Tuberculosis Infection among Immunocompromised Adults","volume":"188","author":"Redelman-Sidi","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.arbres.2020.04.011_bib0235","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis (Edinb)."},{"key":"10.1016\/j.arbres.2020.04.011_bib0240","doi-asserted-by":"crossref","first-page":"e0189202","DOI":"10.1371\/journal.pone.0189202","article-title":"Immune-mediated inflammatory diseases differently affect IGRAs\u2019 accuracy for latent tuberculosis infection diagnosis in clinical practice","volume":"12","author":"Latorre","year":"2017","journal-title":"PLoS ONE."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289620301289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289620301289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:41:50Z","timestamp":1759531310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289620301289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0300289620301289"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2020.04.011","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagn\u00f3stico de la infecci\u00f3n tuberculosa en pacientes inmunodeprimidos y\/o candidatos a terapias biol\u00f3gicas mediante el uso combinado de dos pruebas IGRA: T-SPOT.TB\/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB\/QuantiFERON TB Gold Plus","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}